Issue Code: MED
2,078
497
306
2025--2026
8 activities
CORNERSTONE GOVERNMENT AFFAIRS, INC.
138 activities
VAN SCOYOC ASSOCIATES
48 activities
BALLARD PARTNERS
48 activities
POWERS PYLES SUTTER & VERVILLE, P.C.
43 activities
THE CONAFAY GROUP, LLC
42 activities
DLA PIPER LLP (US)
37 activities
ALSTON & BIRD LLP
36 activities
FORBES-TATE
33 activities
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
33 activities
CROSSROADS STRATEGIES, LLC
31 activities
HOUSE OF REPRESENTATIVES
1,602 mentionsSENATE
1,585 mentionsHealth & Human Services, Dept of (HHS)
442 mentionsNatl Institutes of Health (NIH)
185 mentionsFood & Drug Administration (FDA)
176 mentionsCenters For Medicare and Medicaid Services (CMS)
163 mentionsDefense, Dept of (DOD)
150 mentionsWhite House Office
102 mentionsCenters For Disease Control & Prevention (CDC)
89 mentionsHealth Resources & Services Administration (HRSA)
75 mentionsSANA HEALTH
via TERRAPIN STRATEGY, INC
General Introduction; S 4251 The Veterans Novel Therapeutics Act
NATIONAL GRANGE OF THE ORDER OF PATRONS OF HUSBANDRY
via THE NATIONAL GRANGE OF THE ORDER OF PATRONS OF HUSBANDRY
Small molecules medicines Medicare 340B issues Pharmacy benefit Managers issues General rural health care concerns
INFECTIOUS DISEASES SOCIETY OF AMERICA
via INFECTIOUS DISEASES SOCIETY OF AMERICA
Antimicrobial resistance research, infectious disease product R&D regulatory science, unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policies to allow HIV+ to HIV+ organ transplants, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (H.R.7352/S.4875 119th Congress),Administration Executive Orders regarding HHS, NIH, HRSA, FDA, and CDC, Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act (119th Congress, H.R. 4445/S.4283), SUPERBUGS Act, H.R.7879, 119th Congress.
RARE ACCESS ACTION PROJECT
via COMMONWEALTH POLICY SOLUTIONS
Rare Disease education and advocacy, IRA and Orphan Cures Act
BR.MANNESMAN TECHNOLOGY
via OCAL LOBBYING GROUP
TB Research
SAMERA S.A.
via OCAL LOBBYING GROUP
Planning for mid-year project initiative
TRAVERE THERAPEUTICS
via THE HEALTH EQUITY STRATEGIES GROUP, LLC
Rare kidney disease
AMERICAN ACADEMY OF AUDIOLOGY
via AMERICAN ACADEMY OF AUDIOLOGY
Prevention of elimination of NIH funding FY'2026 LHHS Appropriations Act Early Hearing Detection Intervention Program HR 6718, Professional Student Loan Legislation
HOLY NAME MED CTR
via AWSOM ASSOC
Funding for GME programs and emergency departments
ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE)
via ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE)
Relief from clinical lab reductions in PAMA.